Literature DB >> 8627702

Transfer of single gene-containing long terminal repeats into the genome of mammalian cells by a retroviral vector carrying the cre gene and the loxP site.

A Choulika1, V Guyot, J F Nicolas.   

Abstract

Retroviral vectors contain viral cis-acting elements to achieve the packaging, reverse transcription, integration, and expression of the retroviral genomic nucleic acid sequence. However, these elements are not useful in the integrated provirus and can be the cause of problems. We have developed a vector which eliminates the majority of these viral elements. This vector, a long terminal repeat (LTR) enhancer-deleted vectors, exploits the Cre-lox recombination system of the P1 bacteriophage. The Cre-lox system is neutral for eukaryotic cells. The 32-nucleotide loxP site is inserted within the U3 of the 3' LTR along with with the gene to be transduced (in place of the viral enhancers). Following the LTR-mediated loxP duplication, the LTRs can be recombined by the Cre enzyme. The structure of the resulting provirus in the host genome corresponds to a single LTR (deleted of the viral enhancers) carrying a single copy of the gene to be transduced. If the Cre expression unit is furnished after the integration of a loxP-containing virus, the efficiency of the recombination is not absolute. If the Cre expression unit is inserted between the two LTRs, only single LTR proviral structures are found following infection by the retroviral vector.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627702      PMCID: PMC190005     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

Review 1.  Retroviral gene transfer: applications to human therapy.

Authors:  E Gilboa
Journal:  Prog Clin Biol Res       Date:  1990

2.  A novel system for screening antiretroviral agents.

Authors:  N Savatier; D Rocancourt; C Bonnerot; J F Nicolas
Journal:  J Virol Methods       Date:  1989-11       Impact factor: 2.014

3.  Identification of cellular promoters by using a retrovirus promoter trap.

Authors:  H von Melchner; H E Ruley
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

4.  Transcriptional activation of cKi-ras proto-oncogene resulting from retroviral promoter insertion.

Authors:  S P Trusko; E K Hoffman; D L George
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

5.  Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes.

Authors:  S L Mansour; K R Thomas; M R Capecchi
Journal:  Nature       Date:  1988-11-24       Impact factor: 49.962

6.  Inactivation of the Moloney murine leukemia virus long terminal repeat in murine fibroblast cell lines is associated with methylation and dependent on its chromosomal position.

Authors:  R C Hoeben; A A Migchielsen; R C van der Jagt; H van Ormondt; A J van der Eb
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

7.  Retrovirus promoter-trap vector to induce lacZ gene fusions in mammalian cells.

Authors:  S Reddy; J V DeGregori; H von Melchner; H E Ruley
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

8.  Two blocks in Moloney murine leukemia virus expression in undifferentiated F9 embryonal carcinoma cells as determined by transient expression assays.

Authors:  G Feuer; M Taketo; R C Hanecak; H Fan
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

9.  Evidence for a stem cell-specific repressor of Moloney murine leukemia virus expression in embryonal carcinoma cells.

Authors:  T P Loh; L L Sievert; R W Scott
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

10.  A stem cell-specific silencer in the primer-binding site of a retrovirus.

Authors:  R Petersen; G Kempler; E Barklis
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

View more
  8 in total

1.  Telomerase activity is sufficient to allow transformed cells to escape from crisis.

Authors:  T L Halvorsen; G Leibowitz; F Levine
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

2.  Self-deleting retrovirus vectors for gene therapy.

Authors:  A P Russ; C Friedel; M Grez; H von Melchner
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

3.  A new system for stringent, high-titer vesicular stomatitis virus G protein-pseudotyped retrovirus vector induction by introduction of Cre recombinase into stable prepackaging cell lines.

Authors:  T Arai; K Matsumoto; K Saitoh; M Ui; T Ito; M Murakami; Y Kanegae; I Saito; F L Cosset; Y Takeuchi; H Iba
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

4.  Development of high-titer retroviral producer cell lines by using Cre-mediated recombination.

Authors:  E F Vanin; L Cerruti; N Tran; G Grosveld; J M Cunningham; S M Jane
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

5.  Cre/loxP-mediated excision of a neomycin resistance expression unit from an integrated retroviral vector increases long terminal repeat-driven transcription in human hematopoietic cells.

Authors:  C Fernex; P Dubreuil; P Mannoni; C Bagnis
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

6.  Inhibition of recombinant human immunodeficiency virus type 1 replication by a site-specific recombinase.

Authors:  C C Flowers; C Woffendin; J Petryniak; S Yang; G J Nabel
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

7.  Excision of an integrated provirus by the action of FLP recombinase.

Authors:  D Schübeler; C Mielke; J Bode
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997 Nov-Dec       Impact factor: 2.723

8.  Development of a conditionally immortalized human pancreatic β cell line.

Authors:  Raphaël Scharfmann; Severine Pechberty; Yasmine Hazhouz; Manon von Bülow; Emilie Bricout-Neveu; Maud Grenier-Godard; Fanny Guez; Latif Rachdi; Matthias Lohmann; Paul Czernichow; Philippe Ravassard
Journal:  J Clin Invest       Date:  2014-03-25       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.